Issue Date: October 31, 2016
Heat Biologics eyes Zika vaccine
Heat Biologics has licensed patents from the University of Miami that it will use to develop vaccines against the Zika virus. The Zika program will be directed by Natasa Strbo, a reproductive immunologist at Miami who codeveloped Heat’s gp96-based immunotherapy technology. Heat Biologics currently uses the technology to create therapeutic cancer vaccines. The new Zika vaccines will be developed by a just-formed Heat subsidiary, Zolovax.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society